Table 1 Baseline characteristics of the participants
|  | Control group (n = 14) | MSC-treated group (n = 14) | P value |
|---|---|---|---|
Gender (M/F) | 3/11 | 3/11 | 1.000 |
Age (year) | 17 (15, 24) | 15 (10, 24) | 0.299 |
Duration (month) | 3.8 (0.6, 8.0) | 1.0 (0, 3.3) | 0.171 |
DKA/DK history (case) | 12 | 14 | 0.481 |
BMI (kg/m2) | 18.0 ± 3.3 | 17.3 ± 2.0 | 0.497 |
HbA1c (%) | 9.1 ± 2.4 | 10.6 ± 3.4 | 0.197 |
Islet autoantibody (case) | Â | Â | 1.000 |
 Negative | 2 | 1 |  |
 1 positive | 4 | 6 |  |
 ≥ 2 positive | 8 | 7 |  |
FCP (pmol/L) | 247.9 ± 129.2 | 220.9 ± 138.5 | 0.599 |
PCP (pmol/L) | 564.3 ± 334.0 | 677.3 ± 438.1 | 0.450 |
Insulin doses (U/kg/d) | 0.47 ± 0.15 | 0.62 ± 0.32 | 0.123 |